These publications are examples of research made possible with data from CanPath and its regional cohorts.


Prediction of Cardiovascular Events by Type I Central Systolic Blood Pressure

Authors: Florence Lamarche, Mohsen Agharazii, François Madore, Rémi Goupil

This study assessed which of central or brachial blood pressure best predicts cardiovascular risk and identified the central SBP threshold associated with increased risk of future cardiovascular events. It was concluded that central BP measured with a type I device is statistically but likely not clinically superior to brachial BP in a general population without prior cardiovascular disease.

Read Publication

Predictive value of quantitative ultrasound parameters in individuals with chronic kidney disease: A population-based analysis of CARTaGENE.

Authors: Louis-Charles Desbiens, Remi Goupil, Fabrice Mac-Way

This study showed that early decrease in renal function increase calcancela ultrasound parameters, QUS is associated with fracture incidence regardless of renal function, QUS underestimates fracture incidence in patients with early CKD.

Read Publication

Fracture status in middle-aged individuals with early CKD: cross-sectional analysis of the CARTaGENE survey

Authors: L.C. Desbiens, R. Goupil., A. Sidine., F. Madore., F. Mac-Way

In this cross-sectional analysis, the study team determined that CKD was not correlated with increase fractures, was not a modification factor between calcaneal QUS and fracture, but modified the association between clinical, pharmacological parameters and fracture.

Read Publication

The 2017 American College of Cardiology/American Heart Association vs Hypertension Canada High Blood Pressure Guidelines and Potential Implications

Authors: Remi Goupil, Maxime Lamarre-Cliché, Michel Vallee

This report compared the American and Canadian guidelines of Hypertension Canada and American College of Cardiology and American Heart Association and found that compared to the ACC/AHA guidelines it would result in increases of 8.7% in hypertension diagnosis and 3.4% of individuals needing treatment with 17.2% having a different BP target.

Read Publication